To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene BCDIN3DTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
95 supporting clones for gene BCDIN3D back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CD690663 normal nasopharynx .a 1 to 696 23 to 718   tiling clone,   696/718
(96 %)
8 diff
(98.9 %id)
NM_181708.2   .a 1 to 3248 1 to 3248 exact RefSeq, AAA   3248/3248
(100 %)
0 diff
(100 %id)
BU939955 mixed (pool of 40 RNAs) .a 16 to 764 1 to 756       756/812
(93 %)
17 diff
(98.0 %id)
AK292194 cervix, tumor tissue .a 24 to 1455 1 to 1432 exact     1432/1432
(100 %)
0 diff
(100 %id)
DT217629 brain .a 24 to 692 1 to 669       669/669
(100 %)
1 diff
(99.9 %id)
BP872076 embryonal kidney .a 24 to 609 1 to 587       587/587
(100 %)
1 diff
(99.9 %id)
BF674725 Prostate .a 24 to 729 1 to 716       716/754
(94 %)
23 diff
(97.0 %id)
DB008226 cervix, tumor tissue .a 25 to 510 2 to 489   capped   488/489
(99 %)
3 diff
(99.4 %id)
CN273313 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 33 to 622 9 to 599       591/599
(98 %)
3 diff
(99.5 %id)
CX759949 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 33 to 746 38 to 751     Submitted on the opposite strand 714/751
(95 %)
6 diff
(99.3 %id)
BM546272 ovary (pool of 3) .a 34 to 1048 12 to 1032 T5S F131C Q266P K282E E283G ... available from MGC,   1021/1062
(96 %)
33 diff
(96.9 %id)
BC040957 Ovary, pooled from 3 adults .a 35 to 1483 1 to 1449 S288R available from MGC, AAA   1449/1449
(100 %)
1 diff
(100.0 %id)
CR600896 Placenta Cot 25-normalized .a 36 to 1502 1 to 1467 exact     1467/1467
(100 %)
0 diff
(100 %id)
BX396888 Placenta Cot 25-normalized .a 36 to 796 1 to 761       761/765
(99 %)
3 diff
(99.7 %id)
BG023969 duodenal adenocarcinoma, cell line, small intestine .a 36 to 699 1 to 660       660/1013
(65 %)
10 diff
(99.1 %id)
BC053560 Skin, melanotic melanoma. .a 38 to 1515 1 to 1478 exact tiling clone, available from MGC, AAA   1478/1478
(100 %)
0 diff
(100 %id)
AW248307 lung, small cell carcinoma .a 38 to 600 10 to 572       563/572
(98 %)
6 diff
(99.0 %id)
BM479941 embryonal carcinoma, cell line, testis .a 39 to 1048 1 to 1018 K280X N285K L287F K291N Q292X     1018/1020
(99 %)
24 diff
(97.7 %id)
BU178247 melanotic melanoma, skin .a 40 to 788 1 to 756       756/841
(89 %)
7 diff
(99.2 %id)
CR993151 T-Lymphocytes .a 40 to 802 1 to 763       763/767
(99 %)
1 diff
(99.9 %id)
EL734809 mixed .a 43 to 699 1 to 657       657/657
(100 %)
0 diff
(100 %id)
BE566080 bladder, carcinoma, cell line .a 43 to 658 1 to 598       598/746
(80 %)
39 diff
(94.8 %id)
TI_1948215530   .a 43 to 924 137 to 1027 N232Q Q233S I234D V235C Q236A ... fully sequenced,   891/1027
(86 %)
34 diff
(96.7 %id)
TI_1948215856   .a 43 to 920 138 to 1014   fully sequenced,   877/1014
(86 %)
21 diff
(98.0 %id)
BI488539 brain .a 44 to 971 1 to 939       939/962
(97 %)
40 diff
(95.9 %id)
TI_45379067   .a 44 to 971 82 to 1020       939/1043
(90 %)
46 diff
(95.6 %id)
CX783969 human embryonic stem cells .a 48 to 868 1 to 821       821/821
(100 %)
6 diff
(99.3 %id)
BE886738 leiomyosarcoma, uterus .a 54 to 817 1 to 748       748/914
(81 %)
59 diff
(93.6 %id)
TI_154187960   .a 55 to 643 121 to 709       589/942
(62 %)
22 diff
(97.7 %id)
CR612652 Neuroblastoma Cot 50-normalized .a 56 to 1415 1 to 1360       1360/1360
(100 %)
0 diff
(100 %id)
AL528547 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .a 56 to 928 1 to 864   fully sequenced,   864/864
(100 %)
2 diff
(99.8 %id)
BF969454 adrenal cortex carcinoma, cell line, adrenal gland .a 76 to 836 1 to 759       759/805
(94 %)
19 diff
(97.7 %id)
BE741580 adenocarcinoma cell line, ovary .a 95 to 870 1 to 777       777/778
(99 %)
9 diff
(98.9 %id)
BU188748 melanotic melanoma, skin .a 101 to 947 1 to 854       854/866
(98 %)
13 diff
(98.5 %id)
CN278565 embryonic stem cells, DMSO-treated H9 cellline .a 107 to 532 1 to 426       426/426
(100 %)
0 diff
(100 %id)
BM546219 ovary (pool of 3) .a 125 to 1043 8 to 931       924/1062
(87 %)
22 diff
(98.0 %id)
BE741722 adenocarcinoma cell line, ovary .a 140 to 888 56 to 831       751/1085
(69 %)
33 diff
(97.0 %id)
ES312130 frontal balding hair, skin .a 180 to 355 1 to 179       179/179
(100 %)
3 diff
(98.4 %id)
BM468157 leiomyosarcoma, uterus .a 205 to 1181 1 to 983       983/1039
(94 %)
7 diff
(99.4 %id)
AA313452 colon .a 274 to 589 1 to 316       316/316
(100 %)
0 diff
(100 %id)
TI_1948215531   .a 276 to 920 769 to 123   fully sequenced,   647/769
(84 %)
0 diff
(100 %id)
TI_1948215857   .a 279 to 920 766 to 125   fully sequenced,   642/766
(83 %)
0 diff
(100 %id)
AL528546 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .a 898 to 1415 514 to 1   fully sequenced,   514/514
(100 %)
7 diff
(98.7 %id)
AI634749 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 1096 to 1521 426 to 1       426/426
(100 %)
0 diff
(100 %id)
CA393163 eye, RPE/choroid .a 1504 to 1972 1 to 469   tiling clone,   469/469
(100 %)
1 diff
(99.8 %id)
BI049591 placenta_normal .a 2003 to 2218 219 to 1   tiling clone,   219/358
(61 %)
12 diff
(96.7 %id)
AA193448 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2220 to 2589 1 to 380   tiling clone,   380/395
(96 %)
18 diff
(95.5 %id)
BX094940 liver and spleen .a 2275 to 3071 28 to 824   tiling clone,   797/824
(96 %)
6 diff
(99.3 %id)
R01607 liver and spleen .a 2282 to 2604 1 to 334       334/356
(93 %)
11 diff
(97.0 %id)
BU622810 cell lines, Enchondroma .a 2563 to 3248 704 to 19   AAA   686/686
(100 %)
0 diff
(100 %id)
BG255727 adenocarcinoma, cell line, Prostate .a 2721 to 3250 1 to 530   AAA   530/530
(100 %)
0 diff
(100 %id)
AW000980 Kidney .a 2776 to 3250 476 to 1       476/476
(100 %)
4 diff
(99.2 %id)
R01608 liver and spleen .a 2894 to 3245 363 to 3       361/367
(98 %)
0 diff
(100 %id)
AI083609 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2905 to 3253 352 to 5       348/352
(98 %)
0 diff
(100 %id)
N66881 cochlea, ear .a 3045 to 3252 208 to 1   tiling clone,   208/208
(100 %)
0 diff
(100 %id)
AI468071 anaplastic oligodendroglioma, brain .a 3045 to 3251 207 to 1       207/207
(100 %)
0 diff
(100 %id)
DB081618 testis .b-u 1 to 563 2 to 564   tiling clone, to resequence, capped   563/563
(100 %)
0 diff
(100 %id)
AW896033 nervous_normal .b-u 210 to 530 1 to 321       321/321
(100 %)
1 diff
(99.7 %id)
BX116679 liver and spleen .b-u 687 to 1463 1 to 778   tiling clone,   778/778
(100 %)
1 diff
(99.9 %id)
CR739804 liver and spleen .b-u 687 to 1463 1 to 778       778/778
(100 %)
1 diff
(99.9 %id)
T96856 liver and spleen .b-u 687 to 1026 1 to 346       346/350
(98 %)
13 diff
(96.3 %id)
T85931 liver and spleen .b-u 688 to 1013 1 to 332       332/333
(99 %)
7 diff
(97.9 %id)
AW951927   .b-u 1192 to 1556 1 to 365       365/366
(99 %)
1 diff
(99.8 %id)
AA355961   .b-u 1198 to 1512 1 to 320       320/322
(99 %)
7 diff
(97.9 %id)
BE740503 adenocarcinoma cell line, ovary .b-u 1265 to 1905 1 to 641 exact tiling clone,   641/641
(100 %)
0 diff
(100 %id)
BG757353 B-cells, primary B-cells from tonsils (cell line) .b-u 1388 to 1862 1 to 476       476/824
(57 %)
4 diff
(99.6 %id)
BG755894 B-cells, primary B-cells from tonsils (cell line) .b-u 1388 to 2162 1 to 768       768/768
(100 %)
11 diff
(98.6 %id)
BF128819 B-cells, primary B-cells from tonsils (cell line) .b-u 1408 to 1963 1 to 556       556/556
(100 %)
3 diff
(99.5 %id)
T91067 liver and spleen .b-u 1409 to 1788 393 to 8       386/395
(97 %)
0 diff
(100 %id)
T96857 liver and spleen .b-u 1409 to 1789 381 to 1       381/381
(100 %)
3 diff
(99.3 %id)
AA306184   .b-u 1419 to 1856 1 to 438       438/438
(100 %)
0 diff
(100 %id)
BX369173 Placenta Cot 25-normalized .b-u 1585 to 2419 1 to 840       840/840
(100 %)
57 diff
(93.3 %id)
BX396887 Placenta Cot 25-normalized .b-u 1616 to 2394 777 to 1       777/777
(100 %)
8 diff
(99.0 %id)
TI_1948216012   .b-u 1631 to 1837 334 to 128       207/234
(88 %)
0 diff
(100 %id)
AA658420   .b-u 1637 to 2054 1 to 417       417/417
(100 %)
4 diff
(99.1 %id)
CA307235 Alveolar Macrophage, lung .b-u 1640 to 2345 723 to 19   AAA   705/705
(100 %)
1 diff
(99.9 %id)
TI_1948215692   .b-u 1709 to 1837 253 to 125       129/156
(82 %)
0 diff
(100 %id)
BE544726 cervical carcinoma cell line, cervix .b-u 1836 to 2409 1 to 579       579/589
(98 %)
31 diff
(94.8 %id)
TI_149303649   .b-u 1841 to 2345 594 to 81   AAA   514/823
(62 %)
3 diff
(99.7 %id)
BF058344 fibrotheoma, ovary .b-u 1864 to 2357 497 to 4       494/497
(99 %)
0 diff
(100 %id)
DB340863 testis .b-u 1882 to 2429 548 to 1   tiling clone, to resequence,   548/548
(100 %)
0 diff
(100 %id)
CD369547 Alveolar Macrophage, lung .b-u 1894 to 2345 470 to 19   AAA   452/452
(100 %)
0 diff
(100 %id)
TI_153988912   .b-u 1906 to 2415 601 to 91   AAA   511/514
(99 %)
9 diff
(98.3 %id)
AI921958 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .b-u 1931 to 2354 427 to 4       424/427
(99 %)
0 diff
(100 %id)
AW516322 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b-u 1931 to 2352 422 to 1       422/422
(100 %)
0 diff
(100 %id)
BF058435 fibrotheoma, ovary .b-u 1933 to 2357 428 to 4       425/428
(99 %)
0 diff
(100 %id)
AI803078 pooled .b-u 1940 to 2425 492 to 6       487/492
(98 %)
0 diff
(100 %id)
AW665768 pooled .b-u 1943 to 2418 480 to 5       476/480
(99 %)
0 diff
(100 %id)
AI269723 pooled .b-u 1967 to 2351 385 to 1       385/385
(100 %)
0 diff
(100 %id)
AA826432 carcinoid, lung .b-u 1970 to 2416 446 to 1       446/446
(100 %)
4 diff
(99.2 %id)
AI696181 thymus, pooled .b-u 1978 to 2352 375 to 1       375/375
(100 %)
0 diff
(100 %id)
AA804635 germinal center B cell .b-u 1989 to 2326 339 to 1       339/339
(100 %)
1 diff
(99.8 %id)
AW205112   .b-u 1996 to 2415 437 to 18   AAA   420/420
(100 %)
1 diff
(99.8 %id)
AI094628 brain, glioblastoma (pooled) .b-u 2018 to 2345 365 to 37   AAA   329/329
(100 %)
1 diff
(99.7 %id)
BM981620 lung, Primary Lung Cystic Fibrosis EpithelialCells .b-u 2073 to 2345 291 to 19   AAA   273/273
(100 %)
0 diff
(100 %id)
AI702605 pooled .b-u 2085 to 2423 340 to 1       340/340
(100 %)
1 diff
(99.8 %id)
AA978113 pooled .b-u 2093 to 2418 328 to 4       325/328
(99 %)
0 diff
(100 %id)
FN076427 breast carcinoma .b-u 2147 to 2238 1 to 90       90/102
(88 %)
6 diff
(94.2 %id)
FN151076 breast carcinoma .b-u 2160 to 2270 1 to 111       111/111
(100 %)
0 diff
(100 %id)
AI094651 brain, glioblastoma (pooled) .b-u 2226 to 2345 156 to 37   AAA   120/120
(100 %)
0 diff
(100 %id)
BX334154 Neuroblastoma Cot 50-normalized .c 1 to 1116 1 to 1113 D20B S89X H115X D117X L127X ... tiling clone,   1113/1124
(99 %)
13 diff
(98.9 %id)
DW442272 Liver .c 348 to 570 13 to 235   tiling clone,   223/235
(94 %)
6 diff
(97.5 %id)
? Gene Summary Gene on genome mRNA:.a, .b-u, .c Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DC